drugset / Trial / NCT00791297

Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914

NCT00791297

Phase 2 Completed 55 enrolled Population Council
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to to determine pharmacodynamic effects of a vaginal ring delivering either 1,500 or 2,500 μg of CDB-2914 per day during 6 months of treatment on: 1. follicular function and inhibition of ovulation 2. the endometrium 3. bleeding patterns; and also to assess safety including effects on the endometrium

Timeline

Start
2008-10
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ulipristal Acetate Unknown 1500 ug Other
Comparator Ulipristal Acetate Unknown 2500 ug Other

Indications

No indication recorded.